Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Expert Opinion on Drug Safety
|
September 7, 2023
Drug safety in Africa: a review of systems and resources for pharmacovigilance
Helen Byomire Ndagije, David Walusimbi, Joanita Atuhaire, et al.
Medical Science Educator
|
March 27, 2025
Adequacy of Pharmacovigilance Training in the Health Professional Training Institutions in Uganda: Training Gaps and Opportunities for Improvement
Rajab Kalidi, Henry Kyeyune, Sula Balikuna, et al.
BMC Infectious Diseases
|
November 3, 2025
Understanding causes of incomplete reports of adverse drug reactions associated with dolutegravir-based HIV treatment in uganda: a qualitative study
Henry Zakumumpa, Helen Byomire Ndagije, Joanitah Atuhaire, et al.
Drug Safety
|
April 9, 2018
The Burden of Adverse Drug Reactions Due to Artemisinin-Based Antimalarial Treatment in Selected Ugandan Health Facilities: An Active Follow-Up Study
Helen Byomire Ndagije, Victoria Nambasa, Leonard Manirakiza, et al.
BMC Infectious Diseases
|
August 15, 2022
Patient experiences of sexual dysfunction after transition to dolutegravir-based HIV treatment in mid-Western Uganda: a qualitative study
Henry Zakumumpa, Ronald Kiguba, Helen Byomire Ndagije, et al.
BMC Infectious Diseases
|
December 8, 2021
Provider perspectives on the acceptability and tolerability of dolutegravir-based anti-retroviral therapy after national roll-out in Uganda: a qualitative study
Henry Zakumumpa, Freddy Eric Kitutu, Helen Byomire Ndagije, et al.
Plos One
|
May 10, 2019
The effect of community dialogues and sensitization on patient reporting of adverse events in rural Uganda: Uncontrolled before-after study
Helen Byomire Ndagije, Leonard Manirakiza, Dan Kajungu, et al.
Clinical and Translational Science
|
November 14, 2023
Expanding regulatory science: Regulatory complementarity and reliance
Jackson K Mukonzo, Helen Byomire Ndagije, George Tsey Sabblah, et al.
BMJ Open
|
April 29, 2024
Navigating duplication in pharmacovigilance databases: a scoping review
Ronald Kiguba, Gerald Isabirye, Julius Mayengo, et al.
Journal of Pharmaceutical Policy and Practice
|
March 24, 2023
The impact of the increase in import verification fees on local production capacity of selected medicines in Uganda
Kalidi Rajab, Solomon Onen, Diana Kesi Nakitto, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Expert Opinion on Drug Safety
|
September 7, 2023
Drug safety in Africa: a review of systems and resources for pharmacovigilance
Helen Byomire Ndagije, David Walusimbi, Joanita Atuhaire, et al.
Medical Science Educator
|
March 27, 2025
Adequacy of Pharmacovigilance Training in the Health Professional Training Institutions in Uganda: Training Gaps and Opportunities for Improvement
Rajab Kalidi, Henry Kyeyune, Sula Balikuna, et al.
BMC Infectious Diseases
|
November 3, 2025
Understanding causes of incomplete reports of adverse drug reactions associated with dolutegravir-based HIV treatment in uganda: a qualitative study
Henry Zakumumpa, Helen Byomire Ndagije, Joanitah Atuhaire, et al.
Drug Safety
|
April 9, 2018
The Burden of Adverse Drug Reactions Due to Artemisinin-Based Antimalarial Treatment in Selected Ugandan Health Facilities: An Active Follow-Up Study
Helen Byomire Ndagije, Victoria Nambasa, Leonard Manirakiza, et al.
BMC Infectious Diseases
|
August 15, 2022
Patient experiences of sexual dysfunction after transition to dolutegravir-based HIV treatment in mid-Western Uganda: a qualitative study
Henry Zakumumpa, Ronald Kiguba, Helen Byomire Ndagije, et al.
BMC Infectious Diseases
|
December 8, 2021
Provider perspectives on the acceptability and tolerability of dolutegravir-based anti-retroviral therapy after national roll-out in Uganda: a qualitative study
Henry Zakumumpa, Freddy Eric Kitutu, Helen Byomire Ndagije, et al.
Plos One
|
May 10, 2019
The effect of community dialogues and sensitization on patient reporting of adverse events in rural Uganda: Uncontrolled before-after study
Helen Byomire Ndagije, Leonard Manirakiza, Dan Kajungu, et al.
Clinical and Translational Science
|
November 14, 2023
Expanding regulatory science: Regulatory complementarity and reliance
Jackson K Mukonzo, Helen Byomire Ndagije, George Tsey Sabblah, et al.
BMJ Open
|
April 29, 2024
Navigating duplication in pharmacovigilance databases: a scoping review
Ronald Kiguba, Gerald Isabirye, Julius Mayengo, et al.
Journal of Pharmaceutical Policy and Practice
|
March 24, 2023
The impact of the increase in import verification fees on local production capacity of selected medicines in Uganda
Kalidi Rajab, Solomon Onen, Diana Kesi Nakitto, et al.
Page
of 3